CIC GOOD CLINICAL PRACTICE (GCP) WORKSHOP POSTPONEMENT
Greetings from CIC! Following the current pandemic situation and MCO status in Malaysia, all face-to-face workshops must be postponed until further notice. We are looking
Category: #Update Covid-19
VOLUNTEERS FOR COVID-19 VACCINE
As announced by the Ministry of Health (MOH), there is an additional one (1) clinical trial study involving the COVID-19 vaccine that has been approved
COVID-19 INFORMATION: MOVEMENT CONTROL ORDERS (MCO) 3.0
COVID-19 INFORMATION: MOVEMENT CONTROL ORDERS (MCO) 3.0 The Malaysian government has announced Movement Control Order (MCO) 3.0 from 25th May 2021 until 7th June 2021.
CLINICAL TRIALS FACTSHEET ON COVID-19 WORLDWIDE BY DR. PHAN CHIA WEI, HEAD OF CIC
Factsheet written by Dr Phan Chia Wei, Head of CIC, on clinical trials on COVID-19 worldwide. The factsheet is published by the Academy of Science
UM LEADS CLINICAL TRIALS FOR TOCILIZUMAB IN COVID-19 TREATMENT
Malaysia is embarking on a clinical study to evaluate the drug Tocilizumab for the treatment of severe cases of Covid-19. Led by Universiti Malaya Faculty
UMMC, MOH HOSPITALS STUDYING ARTHRITIS DRUG TREATMENT FOR SEVERE COVID-19
Great news and new hope! CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients. “UMMC has already
